|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/167 | (2006.01) |
| A61K 31/44 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 1567139 |
| (13) | Kind of document | T |
| (96) | European patent application number | 03767663.2 |
| Date of filing the European patent application | 2003-11-26 | |
| (97) | Date of publication of the European application | 2005-08-31 |
| (45) | Date of publication and mention of the grant of the patent | 2008-07-02 |
| (46) | Date of publication of the claims translation | 2008-11-25 |
| (86) | Number | PCT/EP2003/013275 |
| Date | 2003-11-26 |
| (87) | Number | WO 2004/047829 |
| Date | 2004-06-10 |
| (30) | Number | Date | Country code |
| 02026505 | 2002-11-27 | EP |
| (72) |
BEUME, Rolf, DE
BUNDSCHUH, Daniela, CH
KOLASSA, Norbert, DE
MARX, Degenhard, DE
WEIMAR, Christian, DE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Naujas sinergistinis derinys, apimantis roflumilastą ir formoterolį |
| NEW SYNERGISTIC COMBINATION COMPRISING ROFLUMILAST AND FORMOTEROL |
| Payment date | Validity (years) | Amount | |
| 2016-10-19 | 14 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2017-11-26 |